12.63
0.43%
-0.125
Schlusskurs vom Vortag:
$12.76
Offen:
$12.87
24-Stunden-Volumen:
199.62K
Relative Volume:
0.17
Marktkapitalisierung:
$3.61B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$70.76M
KGV:
50.54
EPS:
0.25
Netto-Cashflow:
$103.54M
1W Leistung:
-5.12%
1M Leistung:
-3.38%
6M Leistung:
+3.97%
1J Leistung:
-17.18%
Sotera Health Co Stock (SHC) Company Profile
Firmenname
Sotera Health Co
Sektor
Branche
Telefon
440-262-1410
Adresse
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Vergleichen Sie SHC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
12.61 | 3.61B | 1.12B | 70.76M | 103.54M | 0.25 |
TMO
Thermo Fisher Scientific Inc
|
560.47 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
240.75 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
145.38 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
198.64 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
428.95 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-06 | Eingeleitet | Goldman | Neutral |
2024-05-21 | Eingeleitet | Piper Sandler | Neutral |
2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
2024-03-25 | Hochstufung | Jefferies | Hold → Buy |
2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
2023-06-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2023-01-23 | Hochstufung | JP Morgan | Underweight → Neutral |
2023-01-11 | Hochstufung | Barclays | Underweight → Overweight |
2023-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2022-11-15 | Herabstufung | Barclays | Equal Weight → Underweight |
2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
2022-09-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2022-09-21 | Herabstufung | JP Morgan | Overweight → Underweight |
2022-09-20 | Herabstufung | Goldman | Buy → Neutral |
2022-06-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
2022-03-03 | Herabstufung | Jefferies | Buy → Hold |
2022-03-02 | Herabstufung | Barclays | Overweight → Equal Weight |
2021-03-03 | Eingeleitet | Barclays | Overweight |
2021-01-14 | Eingeleitet | Robert W. Baird | Outperform |
2020-12-15 | Eingeleitet | Citigroup | Buy |
2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
2020-12-15 | Eingeleitet | Goldman | Buy |
2020-12-15 | Eingeleitet | JP Morgan | Overweight |
2020-12-15 | Eingeleitet | Jefferies | Buy |
2020-12-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-12-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Sotera Health Co Aktie (SHC) Neueste Nachrichten
Sotera Health Chairman and CEO Presents at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Sotera Health Projects $1.1B Revenue for 2024, Forecasts 5% Growth at JPM Conference - StockTitan
GAMMA Investing LLC Has $56,000 Stake in Sotera Health (NASDAQ:SHC) - Defense World
Is Sotera Health Company (SHC) the Best Medical Stock to Buy Under $20? - Insider Monkey
SHC (Sotera Health Co) 5-Day RSI : 40.85 (As of Jan. 10, 2025) - GuruFocus.com
SHC (Sotera Health Co) Net Issuance of Preferred Stock : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com
SHCSotera Health Company Latest Stock News & Market Updates - StockTitan
Sotera Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Sotera Health names new lead independent director - Investing.com
Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director - Marketscreener.com
Sotera Health (NASDAQ:SHC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Principal Financial Group Inc. Sells 60,807 Shares of Sotera Health (NASDAQ:SHC) - Defense World
Sotera Health (NASDAQ:SHC) Short Interest Down 18.7% in December - MarketBeat
Sotera Health (NASDAQ:SHC) & American Caresource (OTCMKTS:GNOW) Critical Contrast - Defense World
Sotera Health (NASDAQ:SHC) Stock Position Raised by Geode Capital Management LLC - Defense World
Sotera Health (NASDAQ:SHC) Position Boosted by Geode Capital Management LLC - MarketBeat
Sotera Health (NASDAQ:SHC) Shares Acquired by Fmr LLC - Defense World
Sotera Health Company (SHC) latest stock news and headlines - Yahoo Finance UK
Firstlight Management Urges Sotera Health to Launch a Sale Process - Marketscreener.com
Sotera Health Urged to Sell Nelson Labs Unit for $1.1B Amid UnderperformanceActivist Letter - StockTitan
State Street Corp Has $68.92 Million Stock Holdings in Sotera Health (NASDAQ:SHC) - MarketBeat
Barclays PLC Has $7.91 Million Position in Sotera Health (NASDAQ:SHC) - MarketBeat
At US$12.99, Is It Time To Put Sotera Health Company (NASDAQ:SHC) On Your Watch List? - Yahoo Finance
Sotera Health's SWOT analysis: stock outlook amid litigation, growth plans - Investing.com
Sotera Health (NASDAQ:SHC) Earns Neutral Rating from Analysts at The Goldman Sachs Group - Defense World
Sotera Health (NASDAQ:SHC) Shares Sold by Warburg Pincus LLC - MarketBeat
Jefferies cuts Sotera Health target to $15, keeps buy rating - Investing.com
Janus Henderson Group PLC Has $211.57 Million Stake in Sotera Health (NASDAQ:SHC) - MarketBeat
Top 3 Health Care Stocks That Could Blast Off In December - Benzinga
Captrust Financial Advisors Takes $4.77 Million Position in Sotera Health (NASDAQ:SHC) - MarketBeat
Cerity Partners LLC Invests $1.49 Million in Sotera Health (NASDAQ:SHC) - MarketBeat
Sotera Health Co (SHC) Shares Gap Down to $12.85 on Dec 3 - GuruFocus.com
MIG Capital LLC Has $98.84 Million Position in Sotera Health (NASDAQ:SHC) - MarketBeat
Sotera Health (NASDAQ:SHC) Shares Sold by Gtcr LLC - MarketBeat
Sotera Health's SWOT analysis: stock outlook amid litigation, growth targets - Investing.com
SHC (Sotera Health Co) Enterprise Value : $5,682 Mil (As of Nov. 25, 2024) - GuruFocus.com
Sotera Health (NASDAQ:SHC) Given Outperform Rating at Royal Bank of Canada - Defense World
Sotera Health retains neutral rating, steady shares target on growth outlook - Investing.com
Sotera Health to Share Next Chapter of Growth at 2024 Investor Day - Yahoo Finance
Oversold Conditions For Sotera Health (SHC) - Nasdaq
Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58% - GlobeNewswire Inc.
126,990 Shares in Sotera Health (NASDAQ:SHC) Bought by State of New Jersey Common Pension Fund D - MarketBeat
Sotera Health (NASDAQ:SHC) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Sotera Health's SWOT analysis: sterilization firm's stock shows resilience amid challenges - Investing.com
Private equity-backed Sotera Health looks to raise $1.07 bln in IPO - Reuters.com
Sotera Health Company (SHC) Q3 Earnings Lag Estimates - MSN
Sotera Health (SHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Sotera Health Company (NASDAQ:SHC) Q3 2024 Earnings Call Transcript - Insider Monkey
Wealth Enhancement Advisory Services LLC Invests $850,000 in Sotera Health (NASDAQ:SHC) - MarketBeat
Sotera Health Co (SHC) Shares Gap Down to $15.54 on Nov 7 - GuruFocus.com
Jefferies raises Sotera Health stock outlook, citing higher margin baseline for future growth - Investing.com
Finanzdaten der Sotera Health Co-Aktie (SHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sotera Health Co-Aktie (SHC) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
WARBURG PINCUS & CO. | Director |
Sep 06 '24 |
Sale |
15.03 |
15,000,000 |
225,450,000 |
73,822,952 |
GTCR INVESTMENT XI LLC | Director |
Sep 06 '24 |
Sale |
15.03 |
10,000,000 |
150,300,000 |
49,215,301 |
WARBURG PINCUS & CO. | Director |
Mar 04 '24 |
Sale |
14.31 |
16,594,363 |
237,423,849 |
88,822,952 |
WARBURG PINCUS & CO. | Director |
Mar 04 '24 |
Sale |
14.31 |
16,594,363 |
237,423,849 |
88,822,952 |
GTCR INVESTMENT XI LLC | Director |
Mar 04 '24 |
Sale |
14.31 |
11,062,908 |
158,282,556 |
59,215,301 |
Klee Ann R. | Director |
Mar 04 '24 |
Sale |
14.31 |
5,750 |
82,268 |
86,735 |
Rutz Michael P | President of Sterigenics |
Mar 04 '24 |
Sale |
14.31 |
83,109 |
1,189,082 |
544,409 |
Petras Michael B. Jr. | Chairman & CEO |
Mar 04 '24 |
Sale |
14.31 |
1,003,870 |
14,362,870 |
5,453,580 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):